SuperworthAstronics ATRO
- Market cap
- $2.5B
- PE
- 30.2×
- 10y median 19.8×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 2.6×
- EV/EBIT
- 22.1×
- Revenue, 12 months
- $942.1M
- +14% on a year ago
- Net margin
- 8.4%
- Free cash flow yield
- 2.4%
Astronics trades at 30.2× trailing earnings, pricier than 65% of the last ten years. Revenue was $942.1M over the last twelve months, up 14% on a year earlier with a 8% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $162.9M+24% | $195.3M+24% | $185.1M+18% | $198.1M+14% | $203.7M+25% | $208.5M+7% | $205.9M+11% | $204.7M+3% | $211.4M+4% | $240.1M+15% | $230.6M+12% | $260M+27% | |
| Cost of revenue | $142.3M+22% | $155.3M+14% | $137.6M+7% | $142.5M+1% | $148.5M+4% | $146.4M−6% | $145.1M+6% | $151.9M+7% | $146.9M−1% | $160.1M+9% | $155.5M+7% | $173.1M+14% |
| Gross profit | $20.6M+43% | $40M+86% | $47.5M+73% | $55.6M+70% | $55.2M+168% | $62.1M+55% | $60.8M+28% | $52.8M−5% | $64.5M+17% | $80M+29% | $75.1M+24% | $86.9M+65% |
| R&D | n/a | n/a | $13.3M | $14.2M | $12.5M | $12.1M | $11.1M−17% | $11.6M−19% | $10.2M−18% | $10.6M−12% | $12.1M+9% | $10.9M−6% |
| SG&A | $35.1M+22% | $32.2M+30% | $32.5M+9% | $33.8M+12% | $34.4M−2% | $41.2M+28% | $36.6M+13% | $36.5M+8% | $31.2M−9% | $33.9M−18% | $35.8M−2% | $35.6M−3% |
| −$14.5M+1% | $7.8M | $1.7M | $7.5M+215% | $8.4M | $8.9M+14% | $13.1M+689% | $4.8M−37% | $23.1M+175% | $35.5M+300% | $27.2M+107% | $40.5M+751% | |
| Interest expense | $6M+138% | n/a | $5.8M+5% | $5.9M−1% | $6.2M+4% | n/a | $3.1M−45% | $3.1M−47% | $2.9M−53% | n/a | $2.3M−27% | $2.3M−25% |
| Pre-tax income | −$20.8M+21% | $1.5M | −$4.5M+45% | $1.3M | −$5.2M−75% | $576K−63% | $10.2M | $1.9M+47% | −$12.3M+138% | $32.2M+5498% | $24.8M+144% | $37.9M+1945% |
| −$3.8M+60% | −$5.4M+1169% | −$1.4M | −$274K | $6.6M | $3.4M | $646K | $537K | −$1.2M | $2.6M−23% | −$755K | $2.8M+420% | |
| Net income | −$17M+14% | $7M | −$3.2M−28% | $1.5M | −$11.7M−31% | −$2.8M | $9.5M | $1.3M−14% | −$11.1M−6% | $29.6M | $25.5M+168% | $35.1M+2568% |
| −$0.51+11% | $0.20 | −$0.09−36% | $0.04 | −$0.34−33% | −$0.08 | $0.26 | $0.03−25% | −$0.31−9% | $0.81 | $0.67+158% | $0.75+2400% | |
| 33M+2% | 34.3M+6% | 34.9M+7% | 35.5M+9% | 35M+6% | 35.3M+3% | 43M+23% | 43.6M+23% | 35.4M+1% | 36.7M+4% | 38.2M−11% | 46.5M+7% |
Revenue: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
Cost of revenue: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
Gross profit: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
SG&A: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
Operating income: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
Interest expense: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
Pre-tax income: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
Income tax: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
Net income: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
EPS, diluted: 6 periods, Q1 FY10 to Q4 FY25: quarter's net income to common over its shares, to the cent. Q4 FY10: quarter's net income to common over its shares, to the cent, the shares from counts implied by EPS, near the year's EPS less the nine months'.
Diluted shares: Q1 FY10 and Q1 FY11: share-days: the 6-month average less the second quarter's. 9 periods, Q4 FY11 to Q4 FY23: share-days: the 12-month average less the 9-month, weighted by days. 5 periods, Q4 FY17 to Q4 FY24: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q4 FY25: the earlier year to date counted no dilution: the quarter's basic count plus the later year to date's dilution.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Aerospace & Defense nearest Astronics' size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| ATROAstronics | $2.5B | 30.2× | 19.8× | 2.6× | +14% | 8.4% | |
| HOGHarley-Davidson | $3B | 17.8× | 11.9× | 0.7× | −5% | 4.8% | |
| THOThor Industries | $3.6B | 20.7× | 19.0× | 0.4× | +0% | 1.8% | |
| AIRAAR | $3.8B | 19.5× | 31.9× | 1.1× | +22% | 5.5% | |
| KRMNKarman | $4.9B | 126× | 206× | 8.2× | +50% | 6.3% | |
| LOARLoar | $5.8B | 85.5× | 104× | 9.8× | +30% | 11.6% | |
| SAROStandardAero | $7.2B | 22.5× | 33.3× | 1.1× | +13% | 5.1% | |
| KTOSKratos Defense & Security Solutions | $7.3B | 228× | 177× | 4.8× | +26% | 2.0% | |
| WGOWinnebago Industries | $814.9M | 23.7× | 14.0× | 0.3× | −3% | 1.3% | |
| RGRSturm Ruger | $726.5M | 60.6× | 17.4× | 1.3× | +8% | 2.1% | |
| DRSLeonardo DRS | $9.2B | 29.0× | 38.8× | 2.4× | +10% | 8.5% | |
| Peer median | $4.3B | 26.3× | 32.6× | 1.2× | +12% | 5.0% |
Investors who own it
Investors we follow who held Astronics at the end of Jun 30, 2026, from their 13F filings.
- Polen CapitalPolen Capital0.0% of portfoliotrimmed
More on Astronics
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Its groups
About
- Industry
- Aerospace & Defense
- Sector
- Industrials
Valuation data, not investment advice. Prices as of .